The endoscopic ultrasound (eus)-guided fine needle aspiration market size has grown strongly in recent years. It will grow from $0.7 billion in 2025 to $0.76 billion in 2026 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to limited availability of specialized eus-fna needles, reliance on conventional biopsy methods, growing awareness of early cancer detection, increasing hospital and clinic adoption, standardization of endoscopic ultrasound procedures.
The endoscopic ultrasound (eus)-guided fine needle aspiration market size is expected to see strong growth in the next few years. It will grow to $1.06 billion in 2030 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to technological advancement in powered eus-fna needles, rising prevalence of pancreatic and gastrointestinal cancers, expansion of gastroenterology and oncology clinics, growing demand for minimally invasive procedures, integration with advanced imaging and robotics. Major trends in the forecast period include rising adoption of minimally invasive diagnostic procedures, increasing use of eus-fna in oncology and gastroenterology, growth in powered and manual fine needle aspiration needles, expansion of specialty clinics and ambulatory surgical centers, focus on enhanced sample accuracy and reduced patient discomfort.
The increasing incidence of pancreatic disorders is expected to drive the growth of the endoscopic ultrasound (EUS)-guided fine needle aspiration market in the coming years. Pancreatic disorders encompass diseases and conditions affecting the pancreas, including inflammation, tumors, and functional impairments that influence digestion and hormone production. The rise in these disorders is linked to the growing prevalence of diabetes, which places additional stress on the pancreas and contributes to both inflammatory and functional pancreatic conditions. Endoscopic ultrasound (EUS)-guided fine needle aspiration plays a key role in managing pancreatic disorders by providing minimally invasive, accurate sampling of pancreatic lesions, aiding the diagnosis of conditions such as cancer, cysts, and chronic pancreatitis. For example, in February 2025, Cancer Australia, an Australian government agency, reported that pancreatic cancer caused 3,687 deaths in Australia in 2022 (1,912 males and 1,775 females), increasing to 3,902 deaths in 2024 (2,027 males and 1,875 females). Therefore, the rising prevalence of pancreatic disorders is propelling the growth of the EUS-guided fine needle aspiration market.
Key players in the EUS-guided fine needle aspiration market are focusing on innovations in needle technology, such as endoscopic ultrasound fine biopsy needles, to improve precision and tissue yield during procedures. Endoscopic ultrasound fine biopsy needles are specialized devices designed to obtain core tissue samples during EUS-guided procedures, enabling more accurate histological diagnoses compared to conventional aspiration needles. For instance, in May 2024, Cook Medical, a US-based medical device company, launched the EchoTip ClearCore EUS Biopsy Needle, a next-generation device for precision biopsies of gastrointestinal lesions. This 22-gauge needle is compatible with an ultrasound endoscope for fine needle biopsies (FNB) of submucosal and extramural lesions, mediastinal masses, lymph nodes, and intraperitoneal masses near or within the gastrointestinal tract. It features a cobalt-chromium Franseen tip for enhanced sharpness, allowing tissue puncture with minimal force and precise control, along with a flexible, spring-coiled sheath for access to challenging anatomical locations.
In January 2024, Canon Medical Systems Corporation, a Japan-based medical equipment company, partnered with Olympus Corporation to develop and commercialize advanced endoscopic ultrasound systems. This collaboration aims to provide high-quality diagnostic imaging, improving diagnostic performance and supporting early detection and minimally invasive treatment of diseases, initially targeting markets in Japan and Europe with plans for global expansion. Olympus Corporation, also based in Japan, manufactures optics and reprography products and offers a range of devices for EUS-guided fine needle aspiration (FNA).
Major companies operating in the endoscopic ultrasound (eus)-guided fine needle aspiration market are Medtronic plc, Fujifilm Holdings Corporation, Becton Dickinson and Company, Boston Scientific Corporation, Olympus Corporation, Terumo Corporation, Steris plc, Cook Medical LLC, Canon Medical Systems Corporation, CONMED Corporation, Pentax Medical, Argon Medical Devices Inc., Fannin Limited, Zhejiang Soudon Medical Technology Co. Ltd., Micro-Tech Endoscopy USA Inc., CIVCO Medical Solutions, Medorah Meditek Pvt. Ltd., ACE Medical Devices Pvt. Ltd., ENDO-FLEX GmbH, Limaca Medical Ltd., Medi-Globe GmbH, ZKSK Medical Technology Co. Ltd.
North America was the largest region in the endoscopic ultrasound (EUS)-guided fine needle aspiration market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the endoscopic ultrasound (eus)-guided fine needle aspiration market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the endoscopic ultrasound (eus)-guided fine needle aspiration market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the EUS-guided fine needle aspiration market by increasing costs of imported needles, endoscopes, and related accessories. Segments such as powered FNA needles and core biopsy devices are particularly impacted, with Asia-Pacific regions including China and India facing higher import duties. This has led to increased procurement costs for hospitals and specialty clinics. On the positive side, tariffs are encouraging local manufacturing, material innovations, and investment in domestic production to reduce dependency on imports.
The endoscopic ultrasound (eus)-guided fine needle aspiration market research report is one of a series of new reports that provides endoscopic ultrasound (eus)-guided fine needle aspiration market statistics, including endoscopic ultrasound (eus)-guided fine needle aspiration industry global market size, regional shares, competitors with a endoscopic ultrasound (eus)-guided fine needle aspiration market share, detailed endoscopic ultrasound (eus)-guided fine needle aspiration market segments, market trends and opportunities, and any further data you may need to thrive in the endoscopic ultrasound (eus)-guided fine needle aspiration industry. This endoscopic ultrasound (eus)-guided fine needle aspiration market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) is a minimally invasive diagnostic technique that combines endoscopic ultrasound (EUS) imaging with fine needle aspiration (FNA) to obtain tissue or fluid samples from internal organs or structures. By inserting a thin needle through an ultrasound-equipped endoscope, physicians can access deep internal organs such as the pancreas, lymph nodes, or liver, enabling accurate diagnosis of cancers, cysts, or other abnormalities with minimal invasiveness.
The primary types of EUS-guided fine needle aspiration include enteral endoscopic ultrasound needles and bronchial endoscopic ultrasound needles. Enteral EUS needles are designed for use via the gastrointestinal tract to access and sample organs or structures near the esophagus, stomach, or intestines. Product offerings include manual EUS-FNA needles, powered EUS-FNA needles, procedural accessories, and sample collection devices. These are used for procedures such as tumor diagnosis, cystic lesion evaluation, lymph node biopsies, and solid organ biopsies. EUS-FNA is applied across gastroenterology, oncology, pulmonology, and endocrinology, serving end users such as hospitals, ambulatory surgical centers, specialty clinics, and others.
The endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) market consists of sales of echogenic tip needles, real-time imaging probes, stylet systems, sheath stabilizers, and integrated ultrasound biopsy kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The endoscopic ultrasound (eus)-guided fine needle aspiration market size is expected to see strong growth in the next few years. It will grow to $1.06 billion in 2030 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to technological advancement in powered eus-fna needles, rising prevalence of pancreatic and gastrointestinal cancers, expansion of gastroenterology and oncology clinics, growing demand for minimally invasive procedures, integration with advanced imaging and robotics. Major trends in the forecast period include rising adoption of minimally invasive diagnostic procedures, increasing use of eus-fna in oncology and gastroenterology, growth in powered and manual fine needle aspiration needles, expansion of specialty clinics and ambulatory surgical centers, focus on enhanced sample accuracy and reduced patient discomfort.
The increasing incidence of pancreatic disorders is expected to drive the growth of the endoscopic ultrasound (EUS)-guided fine needle aspiration market in the coming years. Pancreatic disorders encompass diseases and conditions affecting the pancreas, including inflammation, tumors, and functional impairments that influence digestion and hormone production. The rise in these disorders is linked to the growing prevalence of diabetes, which places additional stress on the pancreas and contributes to both inflammatory and functional pancreatic conditions. Endoscopic ultrasound (EUS)-guided fine needle aspiration plays a key role in managing pancreatic disorders by providing minimally invasive, accurate sampling of pancreatic lesions, aiding the diagnosis of conditions such as cancer, cysts, and chronic pancreatitis. For example, in February 2025, Cancer Australia, an Australian government agency, reported that pancreatic cancer caused 3,687 deaths in Australia in 2022 (1,912 males and 1,775 females), increasing to 3,902 deaths in 2024 (2,027 males and 1,875 females). Therefore, the rising prevalence of pancreatic disorders is propelling the growth of the EUS-guided fine needle aspiration market.
Key players in the EUS-guided fine needle aspiration market are focusing on innovations in needle technology, such as endoscopic ultrasound fine biopsy needles, to improve precision and tissue yield during procedures. Endoscopic ultrasound fine biopsy needles are specialized devices designed to obtain core tissue samples during EUS-guided procedures, enabling more accurate histological diagnoses compared to conventional aspiration needles. For instance, in May 2024, Cook Medical, a US-based medical device company, launched the EchoTip ClearCore EUS Biopsy Needle, a next-generation device for precision biopsies of gastrointestinal lesions. This 22-gauge needle is compatible with an ultrasound endoscope for fine needle biopsies (FNB) of submucosal and extramural lesions, mediastinal masses, lymph nodes, and intraperitoneal masses near or within the gastrointestinal tract. It features a cobalt-chromium Franseen tip for enhanced sharpness, allowing tissue puncture with minimal force and precise control, along with a flexible, spring-coiled sheath for access to challenging anatomical locations.
In January 2024, Canon Medical Systems Corporation, a Japan-based medical equipment company, partnered with Olympus Corporation to develop and commercialize advanced endoscopic ultrasound systems. This collaboration aims to provide high-quality diagnostic imaging, improving diagnostic performance and supporting early detection and minimally invasive treatment of diseases, initially targeting markets in Japan and Europe with plans for global expansion. Olympus Corporation, also based in Japan, manufactures optics and reprography products and offers a range of devices for EUS-guided fine needle aspiration (FNA).
Major companies operating in the endoscopic ultrasound (eus)-guided fine needle aspiration market are Medtronic plc, Fujifilm Holdings Corporation, Becton Dickinson and Company, Boston Scientific Corporation, Olympus Corporation, Terumo Corporation, Steris plc, Cook Medical LLC, Canon Medical Systems Corporation, CONMED Corporation, Pentax Medical, Argon Medical Devices Inc., Fannin Limited, Zhejiang Soudon Medical Technology Co. Ltd., Micro-Tech Endoscopy USA Inc., CIVCO Medical Solutions, Medorah Meditek Pvt. Ltd., ACE Medical Devices Pvt. Ltd., ENDO-FLEX GmbH, Limaca Medical Ltd., Medi-Globe GmbH, ZKSK Medical Technology Co. Ltd.
North America was the largest region in the endoscopic ultrasound (EUS)-guided fine needle aspiration market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the endoscopic ultrasound (eus)-guided fine needle aspiration market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the endoscopic ultrasound (eus)-guided fine needle aspiration market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the EUS-guided fine needle aspiration market by increasing costs of imported needles, endoscopes, and related accessories. Segments such as powered FNA needles and core biopsy devices are particularly impacted, with Asia-Pacific regions including China and India facing higher import duties. This has led to increased procurement costs for hospitals and specialty clinics. On the positive side, tariffs are encouraging local manufacturing, material innovations, and investment in domestic production to reduce dependency on imports.
The endoscopic ultrasound (eus)-guided fine needle aspiration market research report is one of a series of new reports that provides endoscopic ultrasound (eus)-guided fine needle aspiration market statistics, including endoscopic ultrasound (eus)-guided fine needle aspiration industry global market size, regional shares, competitors with a endoscopic ultrasound (eus)-guided fine needle aspiration market share, detailed endoscopic ultrasound (eus)-guided fine needle aspiration market segments, market trends and opportunities, and any further data you may need to thrive in the endoscopic ultrasound (eus)-guided fine needle aspiration industry. This endoscopic ultrasound (eus)-guided fine needle aspiration market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) is a minimally invasive diagnostic technique that combines endoscopic ultrasound (EUS) imaging with fine needle aspiration (FNA) to obtain tissue or fluid samples from internal organs or structures. By inserting a thin needle through an ultrasound-equipped endoscope, physicians can access deep internal organs such as the pancreas, lymph nodes, or liver, enabling accurate diagnosis of cancers, cysts, or other abnormalities with minimal invasiveness.
The primary types of EUS-guided fine needle aspiration include enteral endoscopic ultrasound needles and bronchial endoscopic ultrasound needles. Enteral EUS needles are designed for use via the gastrointestinal tract to access and sample organs or structures near the esophagus, stomach, or intestines. Product offerings include manual EUS-FNA needles, powered EUS-FNA needles, procedural accessories, and sample collection devices. These are used for procedures such as tumor diagnosis, cystic lesion evaluation, lymph node biopsies, and solid organ biopsies. EUS-FNA is applied across gastroenterology, oncology, pulmonology, and endocrinology, serving end users such as hospitals, ambulatory surgical centers, specialty clinics, and others.
The endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) market consists of sales of echogenic tip needles, real-time imaging probes, stylet systems, sheath stabilizers, and integrated ultrasound biopsy kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market Characteristics
3. Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market Supply Chain Analysis
4. Global Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market Trends and Strategies
5. Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market Analysis of End Use Industries
7. Global Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Total Addressable Market (TAM) Analysis for the Market
9. Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market Segmentation
10. Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market Regional and Country Analysis
11. Asia-Pacific Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market
12. China Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market
13. India Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market
14. Japan Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market
15. Australia Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market
16. Indonesia Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market
17. South Korea Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market
18. Taiwan Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market
19. South East Asia Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market
20. Western Europe Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market
21. UK Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market
22. Germany Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market
23. France Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market
24. Italy Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market
25. Spain Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market
26. Eastern Europe Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market
27. Russia Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market
28. North America Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market
29. USA Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market
30. Canada Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market
31. South America Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market
32. Brazil Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market
33. Middle East Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market
34. Africa Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market
36. Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market Competitive Landscape and Company Profiles
37. Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market Other Major and Innovative Companies
40. Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses endoscopic ultrasound (eus)-guided fine needle aspiration market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for endoscopic ultrasound (eus)-guided fine needle aspiration? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The endoscopic ultrasound (eus)-guided fine needle aspiration market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Needle Type: Enteral Endoscopic Ultrasound Needles; Bronchial Endoscopic Ultrasound Needles2) By Product Type: Manual Endoscopic Ultrasound-Guided Fine Needle Aspiration (FNA) Needles; Powered Endoscopic Ultrasound-Guided Fine Needle Aspiration (FNA) Needles; Accessories For Endoscopic Ultrasound-Fine Needle Aspiration (FNA) Procedures; Sample Collection Devices
3) By Procedure Type: Endoscopic Ultrasound-Guided Fine Needle Aspiration (FNA) For Tumor Diagnosis; Endoscopic Ultrasound-Guided Fine Needle Aspiration (FNA) For Cystic Lesions; Endoscopic Ultrasound-Guided Fine Needle Aspiration (FNA) For Lymph Node Biopsies; Endoscopic Ultrasound-Guided Fine Needle Aspiration (FNA) For Solid Organ Biopsies
4) By Application: Gastroenterology; Oncology; Pulmonology; Endocrinology
5) By End-User: Hospitals; Ambulatory Surgical Centers; Specialty Clinics; Other End-Users
Subsegments:
1) By Enteral Endoscopic Ultrasound Needles: Aspiration Needles; Biopsy Needles; Core Needles; Fine Needle Biopsy (FNB) Needles; Fine Needle Aspiration (FNA) Needles2) By Bronchial Endoscopic Ultrasound Needles: Transbronchial Aspiration Needles; Biopsy Needles; Echoendoscopic Fine Needles; Fine Needle Aspiration (FNA) Needles; Core Biopsy Needles
Companies Mentioned: Medtronic plc; Fujifilm Holdings Corporation; Becton Dickinson and Company; Boston Scientific Corporation; Olympus Corporation; Terumo Corporation; Steris plc; Cook Medical LLC; Canon Medical Systems Corporation; CONMED Corporation; Pentax Medical; Argon Medical Devices Inc.; Fannin Limited; Zhejiang Soudon Medical Technology Co. Ltd.; Micro-Tech Endoscopy USA Inc.; CIVCO Medical Solutions; Medorah Meditek Pvt. Ltd.; ACE Medical Devices Pvt. Ltd.; ENDO-FLEX GmbH; Limaca Medical Ltd.; Medi-Globe GmbH; ZKSK Medical Technology Co. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration market report include:- Medtronic plc
- Fujifilm Holdings Corporation
- Becton Dickinson and Company
- Boston Scientific Corporation
- Olympus Corporation
- Terumo Corporation
- Steris plc
- Cook Medical LLC
- Canon Medical Systems Corporation
- CONMED Corporation
- Pentax Medical
- Argon Medical Devices Inc.
- Fannin Limited
- Zhejiang Soudon Medical Technology Co. Ltd.
- Micro-Tech Endoscopy USA Inc.
- CIVCO Medical Solutions
- Medorah Meditek Pvt. Ltd.
- ACE Medical Devices Pvt. Ltd.
- ENDO-FLEX GmbH
- Limaca Medical Ltd.
- Medi-Globe GmbH
- ZKSK Medical Technology Co. Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 0.76 Billion |
| Forecasted Market Value ( USD | $ 1.06 Billion |
| Compound Annual Growth Rate | 8.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
